{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:41:15Z","timestamp":1789990875900,"version":"4.0.1"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T00:00:00Z","timestamp":1355961600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0052119","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T21:57:04Z","timestamp":1356040624000},"page":"e52119","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Prophylactic Effect of Probiotics on the Development of Experimental Autoimmune Myasthenia Gravis"],"prefix":"10.1371","volume":"7","author":[{"given":"Chang-Suk","family":"Chae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Keun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Sun","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin-Hyeog","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1472-765X.1995.tb01025.x","article-title":"Inhibition of food-borne pathogenic bacteria by bacteriocins from Lactobacillus gasseri","volume":"21","author":"T Itoh","year":"1995","journal-title":"Lett Appl Microbiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3168\/jds.S0022-0302(95)76784-4","article-title":"Immune system stimulation by probiotics","volume":"78","author":"G Perdigon","year":"1995","journal-title":"J Dairy Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.molimm.2007.12.010","article-title":"Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions","volume":"45","author":"JS So","year":"2008","journal-title":"Mol Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"III54","DOI":"10.1136\/gut.50.suppl_3.iii54","article-title":"Probiotics: a role in the treatment of intestinal infection and inflammation?","volume":"50","author":"E Isolauri","year":"2002","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaci.2005.03.047","article-title":"Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome","volume":"115","author":"M Viljanen","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2006.11.005","article-title":"Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation","volume":"123","author":"N Kim","year":"2007","journal-title":"Clin Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0140-6736(00)04259-8","article-title":"Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial","volume":"357","author":"M Kalliomaki","year":"2001","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1046\/j.1365-2222.2000.00943.x","article-title":"Probiotics in the management of atopic eczema","volume":"30","author":"E Isolauri","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/IAI.69.6.3719-3727.2001","article-title":"Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract","volume":"69","author":"LM Bowman","year":"2001","journal-title":"Infect Immun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaci.2005.03.036","article-title":"Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin","volume":"115","author":"HH Smits","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gut.53.1.108","article-title":"Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis","volume":"53","author":"T Mimura","year":"2004","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/gut.2005.078303","article-title":"Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis","volume":"55","author":"T Kuhbacher","year":"2006","journal-title":"Gut"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1073\/pnas.0904055107","article-title":"Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders","volume":"107","author":"HK Kwon","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse","volume":"190","author":"KV Toyka","year":"1975","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)91917-6","article-title":"Remission of myasthenia gravis following plasma-exchange","volume":"2","author":"AJ Pinching","year":"1976","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1212\/WNL.28.3.266","article-title":"Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange","volume":"28","author":"J Newsom-Davis","year":"1978","journal-title":"Neurology"},{"key":"ref17","first-page":"169","article-title":"Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment","volume":"60","author":"AR Pachner","year":"1987","journal-title":"Yale J Biol Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"BM Conti-Fine","year":"2006","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/310244a0","article-title":"Autoimmune human T lymphocytes specific for acetylcholine receptor","volume":"310","author":"R Hohlfeld","year":"1984","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00005072-198003000-00005","article-title":"Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis","volume":"39","author":"K Sahashi","year":"1980","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.147.4.973","article-title":"Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis","volume":"147","author":"VA Lennon","year":"1978","journal-title":"J Exp Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.4049\/jimmunol.164.10.5236","article-title":"Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL\/6 mice","volume":"164","author":"PI Karachunski","year":"2000","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1096\/fj.01-0072com","article-title":"Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18","volume":"15","author":"SH Im","year":"2001","journal-title":"FASEB J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-5728(01)00474-X","article-title":"Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis","volume":"122","author":"E Goluszko","year":"2002","journal-title":"J Neuroimmunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/intimm\/12.10.1381","article-title":"Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis","volume":"12","author":"HB Wang","year":"2000","journal-title":"Int Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4049\/jimmunol.170.1.604","article-title":"Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL\/6 mice","volume":"170","author":"N Ostlie","year":"2003","journal-title":"J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.4049\/jimmunol.161.6.2856","article-title":"The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis","volume":"161","author":"B Balasa","year":"1998","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1073\/pnas.80.13.4089","article-title":"Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia","volume":"80","author":"CM Gomez","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","article-title":"Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation","volume":"298","author":"DB Drachman","year":"1978","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2004.04.010","article-title":"Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment","volume":"152","author":"PK Maiti","year":"2004","journal-title":"J Neuroimmunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jdermsci.2007.03.002","article-title":"Tolerogenic dendritic cells and regulatory T cells: a two-way relationship","volume":"46","author":"K Mahnke","year":"2007","journal-title":"J Dermatol Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/AEM.65.1.351-354.1999","article-title":"Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption","volume":"65","author":"M Alander","year":"1999","journal-title":"Appl Environ Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.3168\/jds.S0022-0302(97)76233-7","article-title":"Influence of yogurt and acidophilus yogurt on serum cholesterol levels in mice","volume":"80","author":"AS Akalin","year":"1997","journal-title":"J Dairy Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ajcn\/71.2.405","article-title":"Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998","volume":"71","author":"NM de Roos","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1478S","DOI":"10.1093\/jn\/129.7.1478S","article-title":"Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth","volume":"129","author":"BS Reddy","year":"1999","journal-title":"J Nutr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1365-2672.2006.02963.x","article-title":"Probiotics and their fermented food products are beneficial for health","volume":"100","author":"S Parvez","year":"2006","journal-title":"J Appl Microbiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1365-2036.2006.02927.x","article-title":"Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis","volume":"23","author":"MA Zocco","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/gast.2000.9370","article-title":"Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial","volume":"119","author":"P Gionchetti","year":"2000","journal-title":"Gastroenterology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-2249.2007.03434.x","article-title":"Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients","volume":"149","author":"M Lorea Baroja","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0024-3205(98)00315-4","article-title":"Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA\/1 mice","volume":"63","author":"I Kato","year":"1998","journal-title":"Life Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00125-005-1831-2","article-title":"Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse","volume":"48","author":"F Calcinaro","year":"2005","journal-title":"Diabetologia"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e9009","DOI":"10.1371\/journal.pone.0009009","article-title":"A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells","volume":"5","author":"S Lavasani","year":"2010","journal-title":"PLoS One"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(08)60207-X","article-title":"Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial","volume":"371","author":"MG Besselink","year":"2008","journal-title":"Lancet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1196\/annals.1405.034","article-title":"Treatment of myasthenia gravis by preventing acetylcholine receptor modulation","volume":"1132","author":"M Losen","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1172\/JCI8121","article-title":"Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment","volume":"104","author":"SH Im","year":"1999","journal-title":"J Clin Invest"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.169.2.1077","article-title":"Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production","volume":"169","author":"C Deng","year":"2002","journal-title":"J Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.molimm.2008.08.264","article-title":"Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor","volume":"46","author":"HJ Yi","year":"2008","journal-title":"Mol Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/08916930903555943","article-title":"Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction","volume":"43","author":"AM Gomez","year":"2010","journal-title":"Autoimmunity"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.186.3.385","article-title":"Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice","volume":"186","author":"B Balasa","year":"1997","journal-title":"J Exp Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.4049\/jimmunol.178.11.7072","article-title":"C57BL\/6 mice genetically deficient in IL-12\/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells","volume":"178","author":"W Wang","year":"2007","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1111\/j.1365-2567.2009.03089.x","article-title":"Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis","volume":"128","author":"L Mu","year":"2009","journal-title":"Immunology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/86373","article-title":"Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria","volume":"2","author":"M Rescigno","year":"2001","journal-title":"Nat Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000069458","article-title":"Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures","volume":"115","author":"K Shida","year":"1998","journal-title":"Int Arch Allergy Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mai.2002.128528","article-title":"Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients","volume":"110","author":"P Pochard","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/gut.2003.027789","article-title":"Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis","volume":"53","author":"B Sheil","year":"2004","journal-title":"Gut"},{"key":"ref56","first-page":"727","article-title":"Probiotics in IBD: mucosal and systemic routes of administration may promote similar effects","volume":"54","author":"B Foligne","year":"2005","journal-title":"Gut"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nri2132","article-title":"Tolerogenic dendritic cells and the quest for transplant tolerance","volume":"7","author":"AE Morelli","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.4049\/jimmunol.1002539","article-title":"Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis","volume":"186","author":"AM Gomez","year":"2011","journal-title":"J Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.molimm.2008.07.038","article-title":"Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis","volume":"46","author":"JS So","year":"2008","journal-title":"Mol Immunol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.lfs.2010.12.013","article-title":"Lactobacillus casei enhances type II collagen\/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritis","volume":"88","author":"JS So","year":"2011","journal-title":"Life Sci"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1113\/jphysiol.2004.077685","article-title":"Increased ratio of rapsyn to ACh receptor stabilizes postsynaptic receptors at the mouse neuromuscular synapse","volume":"562","author":"OL Gervasio","year":"2005","journal-title":"J Physiol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nbd.2009.03.008","article-title":"Silencing rapsyn in vivo decreases acetylcholine receptors and augments sodium channels and secondary postsynaptic membrane folding","volume":"35","author":"P Martinez-Martinez","year":"2009","journal-title":"Neurobiol Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0052119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:12:38Z","timestamp":1687911158000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0052119"}},"subtitle":[],"editor":[{"given":"Michael","family":"Platten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,20]]},"references-count":62,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0052119","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,20]]}}}